TerminatedNot Applicable

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

Stopped: slower than expected accrual.

United States14 participantsStarted 2022-03-14

Plain-language summary

The purpose of this study is to find out whether factors that lead Women of Color to decline participation in the breast cancer screening trial EA1151 (TMIST) differ from non-women of color.

Who can participate

Age range45 Years – 75 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Participants must be women age 45 or older and under age 75 at the time of study entry. Participant must be scheduled for, or have intent to schedule, a screening mammogram. Participant must be eligible for EA1151/TMIST. Participant must have declined participation in EA1151/TMIST. Participant must be able to complete questionnaires in English. Participant must have a U.S. zip code. Exclusion Criteria:

What they're measuring

Compare the Proportion of Women of Color (WOC) Participants Who Experience the Composite Outcome of COVID-related Financial Hardship vs Non-WOC Participants

Timeframe: at baseline

Trial details

NCT IDNCT05076266

SponsorEastern Cooperative Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2023-02-02

Results submitted2024-02-01

View on ClinicalTrials.gov More Breast Cancer, NOS trials